BCI
AVNS

Brinker Capital Investments’s Avanos Medical AVNS Stock Holding History

Brinker Capital Investments’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-107
Closed -$4K – 338
2019
Q4 		$4K Buy
+107
New +$3.87K ﹤0.01% 681

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Brinker Capital Investments's AVNS Position: Q1 2020 in Review

Brinker Capital Investments sold out of Avanos Medical (AVNS) in Q1 2020, closing a stake of 107 shares — an estimated $4K sold.

Brinker Capital Investments first reported a position in AVNS in Q4 2019 and held it in 1 quarter. The position peaked at $4K in Q4 2019. 272 funds tracked by Wall St. Rank hold AVNS as of Q1 2020.

  • Brinker Capital Investments reported no remaining Avanos Medical position as of Q1 2020 after selling out during the quarter.
  • Brinker Capital Investments sold 107 Avanos Medical shares in Q1 2020, an estimated $4K.
  • Brinker Capital Investments first reported a position in Avanos Medical in Q4 2019 and held it in 1 quarter.
  • Brinker Capital Investments's Avanos Medical position peaked at $4K in Q4 2019.
  • 272 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2020.

Based on Brinker Capital Investments's 13F filing for Q1 2020, filed 13 May 2020.